Important role of 3-methoxytyramine in the inhibition of cocaine sensitization by 1-methyl-1,2,3,4-tetrahydroisoquinoline: an in vivo microdialysis study

Akimoto, 1989, Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studies by in vivo intracerebral dialysis, Brain Res, 490, 339, 10.1016/0006-8993(89)90251-5 Antkiewicz-Michaluk, 2005, 1-Methyl- 1,2,3,4-tetrahydroisoquinoline attenuates ethanol, cocaine and morphine addiction in behavioral models: neurochemical correlates, Acta Neurobiol Exp, 65, P3.01 Antkiewicz-Michaluk, 2007, An endogenous neuroprotectant substance, 1-methyl-1,2 3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats, J Neural Transm, 114, 307, 10.1007/s00702-006-0546-y Antkiewicz-Michaluk, 2003, 1-Methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain, Eur J Pharmacol, 466, 263, 10.1016/S0014-2999(03)01565-6 Antkiewicz-Michaluk, 2006, The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity, J Neurochem, 97, 846, 10.1111/j.1471-4159.2006.03756.x Antkiewicz-Michaluk, 2001, Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties, J Neurochem, 78, 100, 10.1046/j.1471-4159.2001.00391.x Antkiewicz-Michaluk, 2000, Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol, J Neural Transm, 107, 1009, 10.1007/s007020070049 Antkiewicz-Michaluk, 2008, 3-Methoxytyramine, an extraneuronal dopamine metabolite plays a physiological role in the brain as an inhibitory regulator of catecholaminergic activity, Eur J Pharmacol, 599, 32, 10.1016/j.ejphar.2008.09.033 Antkiewicz-Michaluk, 2000, Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain, Neuroscience, 96, 59, 10.1016/S0306-4522(99)00533-3 Antkiewicz-Michaluk, 2004, Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone, Int J Neuropsychopharmacol, 7, 155, 10.1017/S1461145703004036 Berger, 1996, Haloperidol antagonism of cue-elicited cocaine craving, Lancet, 347, 504, 10.1016/S0140-6736(96)91139-3 Campiani, 2003, Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors, J Med Chem, 46, 3822, 10.1021/jm0211220 Carroll, 1994, One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects, Arch Gen Psychiatry, 51, 989, 10.1001/archpsyc.1994.03950120061010 Cornish, 1999, A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior, Neuroscience, 93, 1359, 10.1016/S0306-4522(99)00214-6 De Montis, 1995, Reversal of stable behavioural modifications through NMDA receptor inhibition in rats, Behav Pharmacol, 6, 562, 10.1097/00008877-199508000-00016 De Wit, 1977, Blockade ofcocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine, Can J Psychol, 31, 195, 10.1037/h0081662 Di Chiara, 1995, The role of dopamine in drug abuse viewed from the perspective of its role in motivation, Drug Alcohol Depend, 38, 95, 10.1016/0376-8716(95)01118-I Drouin, 2002, α1b-Adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates, J Neurosci, 22, 2873, 10.1523/JNEUROSCI.22-07-02873.2002 Elkashef, 2006, Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence, Drug Alcohol Depend, 85, 191, 10.1016/j.drugalcdep.2006.04.010 Filip, 2007, Effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the behavioral effects of cocaine in rats, J Physiol Pharmacol, 58, 625 Garcia-Ladona, 2003, BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for treatment of cocaine-addiction, CNS Drug Rev, 9, 141, 10.1111/j.1527-3458.2003.tb00246.x Garzon, 1979, Effect of selective monoamine oxidase inhibitor drugs on morphine tolerance and physical dependence in mice, Neuropharmacology, 18, 531, 10.1016/0028-3908(79)90096-0 Gatch, 2006, Effects of monoamine oxidase inhibitors on cocaine discrimination in rats, Behav Pharmacol, 17, 151, 10.1097/01.fbp.0000197459.08892.b5 Gawin, 1991, Cocaine addiction: psychology and neurophysiology, Science, 251, 1580, 10.1126/science.2011738 Gifford, 1992, Effect of chronic cocaine treatment on D2 receptors regulating the release of dopamine and acetylcholine in the nucleus accumbens and striatum, Pharmacol Biochem Behav, 41, 841, 10.1016/0091-3057(92)90236-9 Goldstein, 2002, Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex, Am J Psychiatry, 159, 1642, 10.1176/appi.ajp.159.10.1642 Grasing, 2005, Effects of high-dose of selegiline on morphine reinforcement and precipitated withdrawal in dependent rats, Behav Pharmacol, 16, 1, 10.1097/00008877-200502000-00001 Grimm, 2003, Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving, J Neurosci, 23, 742, 10.1523/JNEUROSCI.23-03-00742.2003 Guan, 1985, Sensitization of rotational behavior produced by a single exposure to cocaine, Pharmacol Biochem Behav, 22, 901, 10.1016/0091-3057(85)90545-3 Heidbreder, 2005, Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving, Curr Opin Pharmacol, 5, 107, 10.1016/j.coph.2004.08.013 Heikkila, 1984, Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake, Eur J Pharmacol, 103, 241, 10.1016/0014-2999(84)90483-7 Hemby, 1996, The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats, J Pharmacol Exp Ther, 277, 1247 Houtsmuller, 2004, Transdermal selegiline and intravenous cocaine: safety and interactions, Psychopharmacology, 172, 31, 10.1007/s00213-003-1616-6 Howell, 2001, The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates, J Pharmacol Exp Ther, 298, 1 Howell, 2006, Olanzapine-induced suppression of cocaine self-administration in rhesus monkeys, Neuropsychopharmacology, 31, 585, 10.1038/sj.npp.1300828 Hurd, 1989, Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study, Brain Res, 498, 199, 10.1016/0006-8993(89)90422-8 Ishiwata, 2001, Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D2 receptors in the mouse striatum, J Neurochem, 79, 868, 10.1046/j.1471-4159.2001.00619.x Jiménez-Rivera, 2006, Alpha-noradrenergic receptors modulate the development and expression of cocaine sensitization, Ann NY Acad Sci, 1074, 390, 10.1196/annals.1369.039 Juhila, 2005, α2A-Adrenoceptors regulate D-amphetamine-induced hyperactivity and behavioural sensitization in mice, Eur J Pharmacol, 517, 74, 10.1016/j.ejphar.2005.05.022 Kalivas, 2004, Glutamate systems in cocaine addiction, Curr Opin Pharmacol, 4, 23, 10.1016/j.coph.2003.11.002 Kalivas, 1990, The effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens, Synapse, 5, 48, 10.1002/syn.890050104 Kalivas, 1993, Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals, J Neurosci, 13, 266, 10.1523/JNEUROSCI.13-01-00266.1993 Kalivas, 1988, Behavioral and neurochemical effects of acute and daily cocaine administration in rats, J Pharmacol Exp Ther, 245, 485 Karoum, 1994, Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain, Br J Pharmacol, 113, 1391, 10.1111/j.1476-5381.1994.tb17152.x Karoum, 1994, J Neurochem, 63, 972, 10.1046/j.1471-4159.1994.63030972.x Kleven, 1993, Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys, Drug Alcohol Depend, 31, 149, 10.1016/0376-8716(93)90067-Z Kohno, 1986, Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain, Biochem Biophys Res Commun, 140, 448, 10.1016/0006-291X(86)91111-3 Koob, 1997, The neurobiology of drug addiction, J Neuropsychiatry Clin Neurosci, 9, 482, 10.1176/jnp.9.3.482 Kotake, 2005, Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins, Brain Res, 1033, 143, 10.1016/j.brainres.2004.11.019 Kuhar, 1991, The dopamine hypothesis of the reinforcing properties of cocaine, Trends Neurosci, 14, 299, 10.1016/0166-2236(91)90141-G Le Foll, 2005, The dopamine D3 receptor and drug dependence: effects on reward or beyond?, Neuropharmacology, 49, 525, 10.1016/j.neuropharm.2005.04.022 Le Foll, 2000, Dopamine D3 receptor agents as potential new medications for drug addictions, Eur Psychiatry, 15, 140, 10.1016/S0924-9338(00)00219-4 Lienau, 1997, Sensitization phenomena after repeated administration of cocaine or D-amphetamine in rats: associative and non-associative mechanisms and the role of dopamine in the striatum, Naunyn Schmiedeberg’s Arch Pharmacol, 355, 531, 10.1007/PL00004979 Mach, 2004, Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands, Chembiochem, 5, 508, 10.1002/cbic.200300784 Mc Naught, 1994, An overview of the mechanism of action of clozapine, J Clin Psychiat, 55, 47 Meil, 1997, Olanzapine attenuates the reinforcing effects of cocaine, Eur J Pharmacol, 340, 17, 10.1016/S0014-2999(97)01351-4 Moore, 1998, Effect of cocaine self-administration on striatal dopamine D1 receptors in rhesus monkeys, Synapse, 28, 1, 10.1002/(SICI)1098-2396(199801)28:1<1::AID-SYN1>3.0.CO;2-G Moore, 1998, Effect of cocaine self-administration on striatal dopamine D2 receptors in rhesus monkeys, Synapse, 30, 88, 10.1002/(SICI)1098-2396(199809)30:1<88::AID-SYN11>3.0.CO;2-L Narayanan, 1996, Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens, Pharmacol Biochem Behav, 54, 565, 10.1016/0091-3057(95)02220-1 Ossowska, 2005, Influence of paraquat on dopaminergic transporter in the rat brain, Pharmacol Rep, 57, 330 Patsenka, 2004, Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds -1,2,3,4-tetrahydroisoquinoline alkaloids, Pol J Pharmacol, 56, 727 Peris, 1987, One injections of cocaine produces a long-lasting increase in [3H]-dopamine release, Pharmacol Biochem Behav, 27, 533, 10.1016/0091-3057(87)90361-3 Pettit, 1990, Extracellular concentration of cocaine and dopamine are enhanced during chronic cocaine administration, J Neurochem, 55, 798, 10.1111/j.1471-4159.1990.tb04562.x Pierce, 1997, A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants, Brain Res Rev, 25, 192, 10.1016/S0165-0173(97)00021-0 Pietraszek, 2009, Neurotox Res, 16, 390, 10.1007/s12640-009-9097-y Pilla, 1999, Selective inhibition of cocaine-seeking behavior by a partial dopamine D3 receptor agonist, Nature, 400, 371, 10.1038/22560 Preti, 2000, BP-897 Bioprojet, Curr Opin Investig Drugs, 1, 110 Pulvirenti, 1992, NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat, Brain Res, 594, 327, 10.1016/0006-8993(92)91145-5 Reith, 1986, Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior, Biochem Pharmacol, 35, 1123, 10.1016/0006-2952(86)90148-6 Ritz, 1987, Cocaine receptors on dopamine transporters are related to self-administration of cocaine, Science, 237, 1219, 10.1126/science.2820058 Robinson, 1993, The neural basis of drug craving: an incentive-sensitization theory of addiction, Brain Res Rev, 18, 247, 10.1016/0165-0173(93)90013-P Schiffer, 2003, Selegiline potentiates cocaineinduced increases in rodent nucleus accumbens dopamine, Synapse, 48, 35, 10.1002/syn.10183 Segal, 1981, Stimulant-induced psychosis: an evaluation of animal methods, Essays Neurochem Neuropharmacol, 5, 95 Segal, 1992, Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens, Brain Res, 577, 351, 10.1016/0006-8993(92)90297-M Smelson, 2004, A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients, J Subst Abuse Treat, 27, 45, 10.1016/j.jsat.2004.03.009 Tzschentke, 2003, Glutamatergic mechanisms in addiction, Mol Psychiatry, 8, 373, 10.1038/sj.mp.4001269 Vetulani, 2001, Drug addiction. Part II. Neurobiology of addiction, Pol J Pharmacol, 53, 303 Vetulani, 2003, A possible physiological role for cerebral tetrahydroisoquinolines, Neurotox Res, 5, 147, 10.1007/BF03033379 Villegier, 2003, Stimulation of postsynaptic α1b- and α2-adrenergic receptors ampliflies dopamine-mediated locomotor activity in both rats and mice, Synapse, 50, 277, 10.1002/syn.10267 Volkow, 1997, Relationship between subjective effects of cocaine and dopamine transporter occupancy, Nature, 386, 827, 10.1038/386827a0 Wąsik, 2005, An endogenous compound 1-methyl-1,2,3,4-tetrahydroiso-quinoline prevents the morphine addiction in rat: the view on neurochemical mechanism of action, Eur Neuropsychopharmacol, 15, 22, 10.1016/S0924-977X(05)80132-4 Wąsik, 2007, The effect of an endogenous compoud 1-methyl-1,2,3,4-tetrahydroisoquinoline on morphine-induced analgesia, dependence and neurochemical changes in dopamine metabolism in rat brain structures, J Physiol Pharmacol, 58, 235 Wise, 1984, Neural mechanisms of the reinforcing action of cocaine, NIDA Res Monogr, 50, 15 Woolverton, 1986, Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys, Pharmacol Biochem Behav, 24, 531, 10.1016/0091-3057(86)90553-8 Woolverton, 1992, Neurobiology of cocaine abuse, Trends Pharmacol Sci, 13, 193, 10.1016/0165-6147(92)90063-C Zhang, 2001, Comparison of cocaine- and amphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions, Ann NY Acad Sci, 937, 93, 10.1111/j.1749-6632.2001.tb03560.x